Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science.
The history of Novartis started in the middle of the 18th century. Novartis, as we know it today, was founded in 1996 by the merger of three companies.
Learn more about treatments currently offered by Novartis Innovative Medicines and Advanced Accelerator Applications.
Innovative Medicines, made up of two separate commercial organizations, Innovative Medicines International and Innovative Medicines US, commercializes innovative patented medicines to enhance health outcomes.
Novartis Corporate Center
Novartis Corporate Center, Prague, is one of six strategically located corporate centers established by Novartis globally. It brings together expert capabilities and talent across functions, and is an innovation hub that drives the business forward. It is home to ~1500 associates of 80+ nationalities who work to deliver on the Novartis purpose of reimagining medicine to improve and extend people’s lives.
Global Drug Development (GDD)
GDD oversees the development of new medicines and manages Novartis clinical trials to bring innovative medicines to patients.
Novartis Institutes for Biomedical Research (NIBR)
NIBR collaborates across scientific and organizational boundaries, focusing on powerful new technologies to help produce therapeutic breakthroughs.